<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Table</title>
    <link rel="stylesheet" href="style.css">
</head>
<body>
    <table class="center">        
          <colgroup>
            <col style="background-color:#ADD8E6">
            <col style="background-color:white">
            <col style="background-color:pink">
            <col style="background-color:#FFFFE0">
          </colgroup>

        <thead >
        <tr>
            <th>Company</th>
            <th>Collaboration</th>
            <th>Cell type</th>
            <th>application</th>
        </tr>
        </thead>
        <tr>
            <th>Advance Cell Technology</th>
            <td>orgon health & science university (OHSU)
                <ul>
                    <li>Moorfield Eye Hosp</li>
                    <li>UCLA /Jules Stein</li>
                    <li>Wills Eye Hospital</li>
                    <li>Aberdeen Royal Infirm</li>
                    <li>Bascom Palmer</li>
                </ul>
            </td>
            <td>hESCs</td>
            <td>RPE cells for retinal diseases,including Dry AMD <span> NCT01344993 </span> and stargrant's
                    <span>NCT01345006</span> <span>NCT01469832</span></td>
        </tr>
        <tr>
            <th>AstraZenica</th>
            <td>Univ. Collage london (UCL)</td>
            <td>hESCs</td>
            <td>Diabetic Retinopathy</td>
        </tr>
        <tr>
            <th>Centecor/J&J w/iScience <br>interventional</th>
            <td>
                <ul>
                    <li>Retina Institute of CA</li>
                    <li>Wills Eye Hospital</li>
                </ul>
            </td>
            <td>Adult SCs (CNTO 2746 from umbilical cord fluid)</td>
            <td>RPE cells for GA (atrophic dry AMD) <span>NCT01226628</span></td>
        </tr>
        <tr>
            <th>Cell Cure Neurosciences</th>
            <td>TEVA</td>
            <td>hESCs</td>
            <td>RPE cells for dry AMD</td>
        </tr>
        <tr>
            <th>CellSeed France SARL</th>
            <td>FGK Clinical Research GmbH
                <ul>
                    <li>universitatsklinkum,Erlangen, Germany</li>
                </ul>
            </td>
            <td>Oral mucosa epithielial cells</td>
            <td>CAOMESC* for Corneal tissue repair in those with limbal cell deficiencies <span>NCT01470573</span></td>
        </tr>
        <tr>
            <th>Fundacian clinic per a la Recerea Biomedica (Spain) </th>
            <td>
                <ul>
                    <li>Hopital clinic Barcelona</li>
                    <li>Instituto Univ. Barraquer </li>
                    <li>Instituto de Microcirugia Ocular</li>
                </ul>
            </td>
            <td>Selerocomeal progenitor cells from the limbus</td>
            <td>replacement of damaged corneal cells <span>NCT01470573</span></td>
        </tr>
        <tr>
            <th>General Hosp Of the Chinese People's Armed police force (Chaina)</th>
            <td></td>
            <td>unknown/td>
            <td>Optic Nerve Atrophy <span>ChiCTR-TNRC-11001491</span></td>
        </tr>
        <tr>
            <th>interventional Stem Cell Corp. (ISCO)</th>
            <td>CytoCor-
                <ul>
                    <li>Absorption Systems-US</li>
                    <li>Sankara Netaralaya-India</li>
                    <li>Automation Partnerships-Uk</li>
                </ul>
                CytoRet-UC Irvine
            </td>
            <td>hpScs <br><br><br><br><br> hpScs</td>
            <td>Corneal tissue for transplation into degented cornease <br><br><br>
                RPE cells and layered retinal structure for AMD
            </td>
        </tr>
    </table>
</body>

</html>